Disc Medicine Inc. (IRON) Stock Analysis

Disc Medicine Inc. (IRON) is a publicly traded company in the HEALTHCARE sector. It trades at $68.00, carries a market capitalization of $2.75B. This page summarizes the public market data, fundamentals, and frequently asked questions for IRON, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $68.00
• Market Cap: $2.75B
• EPS: $-6.64
• 52-Week High: $99.50
• 52-Week Low: $40.00

Market Sentiment

Disc Medicine Inc. currently has a Bullish sentiment score of 0.23.

About Disc Medicine Inc.

Disc Medicine Inc. (IRON) is a clinical-stage biotechnology company headquartered in Watertown, Massachusetts, dedicated to the advancement of innovative therapies for patients with serious hematologic diseases. The company boasts a comprehensive pipeline designed to target significant unmet medical needs in hematology, utilizing state-of-the-art drug development methodologies and thorough scientific research. Disc Medicine is strategically positioned to reshape the treatment paradigm for hem...

GNG Research Analysis

GNG Research scores Disc Medicine Inc. (IRON) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IRON.

Frequently Asked Questions

Does IRON pay dividends?

Disc Medicine Inc. (IRON) does not currently pay a regular dividend.

What is IRON's market cap?

Disc Medicine Inc. (IRON) has a market capitalization of $2.75B with a current stock price of $68.00.